Aspen Aerogels (NYSE:ASPN) Issues Earnings Results

Aspen Aerogels (NYSE:ASPN) issued its earnings results on Thursday. The construction company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01), FiscalAI reports. The business had revenue of $37.88 million during the quarter, compared to the consensus estimate of $36.58 million. Aspen Aerogels had a negative return on equity of 20.79% and a negative net margin of 48.64%.The company’s revenue for the quarter was down 51.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. Aspen Aerogels updated its Q2 2026 guidance to -0.240–0.17 EPS.

Here are the key takeaways from Aspen Aerogels’ conference call:

• Management reported an explosion and temporary shutdown at the East Providence plant, with a staged restart expected in May, creating short-term supply disruption and elevated costs from expedited freight and repairs.
• Aspen expects ~20% revenue growth in Energy Industrial for 2026, driven by growing Subsea awards, an anticipated ~2x increase in LNG activity, and maintenance/turnaround opportunities, and aims to scale the segment to a $200M high‑margin business without incremental capex.
• Thermal Barrier momentum is concentrated in Europe—Q1 EU revenue was >3x year‑ago and Aspen targets roughly $10M–$15M from European OEM programs in 2026—while the company is also pursuing battery energy storage system qualifications with potential initial revenue in 2026.
• Q2 guidance calls for revenue of $40M–$48M and Adjusted EBITDA of −$10M to −$4M; liquidity is strong with $175.6M cash (ample covenant headroom), but the company expects possible Q2 cash outflows of $20M–$30M depending on supply mitigation and inventory build.

Aspen Aerogels Stock Down 1.4%

NYSE ASPN traded down $0.07 during mid-day trading on Friday, hitting $5.05. The company’s stock had a trading volume of 2,011,581 shares, compared to its average volume of 1,828,986. The company’s 50 day simple moving average is $3.46 and its 200 day simple moving average is $3.79. Aspen Aerogels has a twelve month low of $2.30 and a twelve month high of $9.78. The company has a current ratio of 3.90, a quick ratio of 3.29 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of $418.04 million, a price-to-earnings ratio of -3.71 and a beta of 2.83.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ASPN shares. Barclays lowered their target price on Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating for the company in a report on Thursday, March 5th. TD Cowen lowered their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Friday, March 27th. Roth Mkm reiterated a “buy” rating and issued a $5.75 target price on shares of Aspen Aerogels in a report on Friday. Finally, Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $4.94.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently bought and sold shares of ASPN. WINTON GROUP Ltd acquired a new stake in Aspen Aerogels in the 4th quarter valued at $40,000. StoneX Group Inc. acquired a new stake in Aspen Aerogels in the 4th quarter valued at $41,000. Acadian Asset Management LLC acquired a new stake in Aspen Aerogels in the 1st quarter valued at $43,000. Tower Research Capital LLC TRC grew its position in Aspen Aerogels by 184.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after purchasing an additional 4,693 shares during the period. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in Aspen Aerogels in the 4th quarter valued at $58,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.